Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation

European Journal of Haematology

Volumn 83, Issue 5, 2009, Pages 455-459

  Sahlstedt, Leila ^a   Von Bonsdorff, Leni ^b   Ebeling, Freja ^a   Parkkinen, Jaakko ^a,b   Juvonen, Eeva ^a   Ruutu, Tapani ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Autologous stem cell transplantation; Chemotherapy; Iron; Non transferrin bound iron; Transferrin saturation

Indexed keywords

AMSACRINE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROXYL RADICAL; IDARUBICIN; IRON; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; NON TRANSFERRIN BOUND IRON; TIOGUANINE; TRANSFERRIN; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CHRONOLOGY; CLINICAL ARTICLE; DRUG CYTOTOXICITY; DRUG EFFECT; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON BLOOD LEVEL; LEUKOCYTE COUNT; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IRON; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSFERRIN; TRANSPLANTATION, AUTOLOGOUS;

EID: 70349958241     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01310.x     Document Type: Article

References (19)

1. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology 1986 90 : 770 784.
2. Bearman SI, Appelbaum FR, Bruckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988 6 : 1562 1568.
3. McCord JM. Iron, free radicals, and oxidative injury. Semin Hematol 1998 35 : 5 12.
4. Carmine TC, Evans P, Bruchelt G, Evans R, Handgretinger R, Niethammer D, Halliwell B. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Lett 1995 94 : 219 226.
5. Gordon LI, Brown SG, Tallman MS, et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radic Biol Med 1995 18 : 383 389.
6. Bullen JJ. The significance of iron in infection. Rev Infect Dis 1981 3 : 1127 1138.
7. Harrison P, Marwah SS, Hughes RT, Bareford D. Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. J Clin Pathol 1994 47 : 350 352.
8. Sahlstedt L, Ebeling F, von Bondsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol 2001 113 : 836 838.
9. von Bonsdorff L, Lindeberg E, Sahlstedt L, Lehto J, Parkkinen J. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies. Clin Chem 2002 48 : 307 314.
10. Anderson GJ. Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999 14 : 105 108.
11. Smirnov IM, Bailey K, Flowers CH, Garrigues NW, Wesselius LJ. Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol 1999 277 : L257 63.
12. Juvonen E, Sahlstedt L, Parkkinen J, Ruutu T. Inhibition of erythroid and granulocyte-macrophage colony formation by non-transferrin-bound iron in vitro: protective effect of apotransferrin. Eur J Haematol 2007 79 : 126 131.
13. Beare S, Steward WP. Plasma free iron and chemotherapy toxicity. Lancet 1996 347 : 342 343.
14. de Witte T. The role of iron in patients after bone marrow transplantation. Blood Rev 2008 22 (SUPPL. 2 S22 8.
15. Iglesias-Osma C, Gonzalez-Villaron L, San Miguel JF, Caballero MD, Vazquez L, de Castro S. Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol 1995 48 : 223 225.
16. Altes A, Remacha AF, Sarda P, Baiget M, Canals C, Sierra J. The relationship between transferrin saturation and erythropoiesis during stem cell transplantation. Haematologica 2006 91 : 992 993.
17. Hershko C. Mechanism of iron toxicity. Food Nutr Bull 2007 28 (SUPPL. 4 S500 9.
18. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 2001 97 : 792 798.
19. Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Br J Haematol 2002 119 : 547 553.